RXRX - What's Going On With Recursion Pharmaceuticals Stock On Thursday? | Benzinga
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher after Nvidia Corp (NASDAQ:NVDA), in its 13F filing, disclosed a small stake in the company.
As per the SEC filing, Nvidia’s stake in Recursion Pharmaceuticals was valued at $75.9 million, with 7.7 million shares.
In July 2023, Nvidia disclosed a $50 million investment in Recursion.
Founded in 2013, Recursion Pharmaceuticals combines experimental biology, bioinformatics, and artificial intelligence in a hybrid lab-to-cloud platform to identify treatments for any disease that can be modeled at the cellular level.
“Generative AI is a revolutionary tool to discover new medicines and treatments,” said Jensen Huang, founder and CEO of NVIDIA, in July 2023.
In its press release, Recursion said it ...